Phase II Trial for an Oral Peptide to Treat Plaque Psoriasis
Dr. Ronald B. Vender discusses the late breaking study that everyone is talking about, an oral peptide to treat moderate-to-severe plaque psoriasis.
top of page
it's where dermatology lives
bottom of page
Comments